Gottlieb: FDA Will Clear Backlog of Orphan Drug Requests Within 90 Days

Drug Industry Daily
The FDA will clear its backlog of orphan drug designation requests in the next 90 days, Commissioner Scott Gottlieb told Senate appropriators, and the agency plans to assign a team dedicated to assessing the approximately 200 applications currently pending.

To View This Article:


Subscribe To Drug Industry Daily